The global intravenous (IV) therapy and vein access market was valued at $22,808.93 million in 2020 and is projected to reach $ 37,537.18 million by 2030, registering a CAGR of 5.2% from 2021 to 2030. Intravenous therapy (IV) is a medical technique that transfers fluids, medications, and nutrients directly into the veins of the patient. The intravenous route of administration is commonly used for rehydration or to provide nutrients for those who cannot, or will not-due to reduced mental states or otherwise-consume food or water by mouth. In addition, it is used to administer medications or other medical fluids, including blood products or electrolytes to correct electrolyte imbalances.. It is used for the treatment of diseases, including heart attack, stroke, and poisoning. In such cases, the patient must receive medication at the earliest, and hence IV medication is prescribed.
The key factors that drive the growth of IV therapy and vein access devices market include rise in incidence & prevalence of chronic diseases, growth in road accidents, and surge in trauma cases. In addition, an increase in healthcare expenditure and healthcare insurance is expected to fuel the market growth during the forecast period. However, the lack of experienced healthcare professionals restricts the market growth. Conversely, the rise in critical care therapies and the increase in the geriatric population are the key factors driving the growth of the market.
Furthermore, the intravenous (IV) therapy and vein access market is segmented on the basis of type, medical application, and region. On the basis of type, the market is segmented into implantable ports, IV catheters, hypodermic needles, infusion pumps, and other products. By medical application, it is categorized into volume expanders, medication administration, blood-based products, and nutrition & buffer solutions. As per end-user, the market is fragmented into hospitals, ambulatory surgical centers, and clinics. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players operating in the global IV therapy & vein access market include Becton, Dickinson & Company, Braun Melsungen AG, Terumo medical corporation, Teleflex Medical Inc., Medtronic Inc., Angiodynamic, Inc.., Smith& Nephew Plc., Pfizer Inc., Insulet Corporation, and Fresenius SE& CO. KGAA.
The other players (the profiles of these players are not covered in the report) in the value chain include Baxter International Inc., iRadimed Corporation, BioScrip, Inc., Grifols, S.A., JW Life Science Co. Ltd., BRIEF-Sichuan Kelun Pharmaceutical Co. Ltd., CVS Health Corporation, and Vifor Pharma Group.
The key factors that drive the growth of IV therapy and vein access devices market include rise in incidence & prevalence of chronic diseases, growth in road accidents, and surge in trauma cases. In addition, an increase in healthcare expenditure and healthcare insurance is expected to fuel the market growth during the forecast period. However, the lack of experienced healthcare professionals restricts the market growth. Conversely, the rise in critical care therapies and the increase in the geriatric population are the key factors driving the growth of the market.
Furthermore, the intravenous (IV) therapy and vein access market is segmented on the basis of type, medical application, and region. On the basis of type, the market is segmented into implantable ports, IV catheters, hypodermic needles, infusion pumps, and other products. By medical application, it is categorized into volume expanders, medication administration, blood-based products, and nutrition & buffer solutions. As per end-user, the market is fragmented into hospitals, ambulatory surgical centers, and clinics. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players operating in the global IV therapy & vein access market include Becton, Dickinson & Company, Braun Melsungen AG, Terumo medical corporation, Teleflex Medical Inc., Medtronic Inc., Angiodynamic, Inc.., Smith& Nephew Plc., Pfizer Inc., Insulet Corporation, and Fresenius SE& CO. KGAA.
The other players (the profiles of these players are not covered in the report) in the value chain include Baxter International Inc., iRadimed Corporation, BioScrip, Inc., Grifols, S.A., JW Life Science Co. Ltd., BRIEF-Sichuan Kelun Pharmaceutical Co. Ltd., CVS Health Corporation, and Vifor Pharma Group.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the intravenous (iv) therapy and vein access market analysis from 2020 to 2030 to identify the prevailing intravenous (iv) therapy and vein access market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the intravenous (iv) therapy and vein access market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global intravenous (iv) therapy and vein access market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Type
- Implantable Ports
- Intravenous Catheters
- Hypodermic Needles
- Infusion Pumps
- Other
By Medical Application
- Nutrition And Buffer Solution
- Volume Expander
- Medication Administration
- Blood Based Products
By End User
- Hospitals
- Ambulatory Surgical Center
- Clinics
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest Of Asia Pacific
- LAMEA
- Brazil
- South Africa,
- Saudi Arabia
- Rest of LAMEA
Key Market Players
- Medtronic Inc
- Teleflex
- B. Braun Melunsung
- terumo corporation
- AngioDynamics, Inc.
- Fresenius SE and Co. KGaA.
- Baxter international plc
- Pfizer Inc
- Cardinal Health Inc.
- smiths medical
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: INTRAVENOUS (IV) THERAPY AND VEIN ACCESS MARKET, BY TYPE
CHAPTER 5: INTRAVENOUS (IV) THERAPY AND VEIN ACCESS MARKET, BY MEDICAL APPLICATION
CHAPTER 6: INTRAVENOUS (IV) THERAPY AND VEIN ACCESS MARKET, BY END USER
CHAPTER 7: INTRAVENOUS (IV) THERAPY AND VEIN ACCESS MARKET, BY REGION
CHAPTER 8: COMPANY LANDSCAPE
CHAPTER 9: COMPANY PROFILES
LIST OF TABLES
LIST OF FIGURES
Executive Summary
The Intravenous Therapy and Vein Access Market size was valued at $22.8 billion in 2020, and is estimated to reach $37.5 billion by 2030, growing at a CAGR of 5.1% from 2021 to 2030.(IV) therapy is one of the most frequently used health care therapies. It is performed in emergency response settings, hospitals, clinics, nursing homes, and, at an individual's home. IV therapy is used for many reasons, including restoration of fluids in dehydrated patients. In patients with severe vomiting and/or diarrhea, especially in children, dehydration can be fast and severe. IV therapy transfers and replaces fluids and electrolytes, providing rest to the digestive system rest.
Intravenous Therapy and Vein Access Market trends are an increase in patients with diabetes, an increase in rates of road accidents, and a surge in the number of surgical procedures are expected to drive the growth of the market. An increase in demand for advanced techniques, including needleless administration of drugs drives the market growth. However, the lack of experienced healthcare professionals restricts the market growth. Some factors that influence the advancement of this market include rise in critical care therapies required by the geriatric population and the rise in healthcare facilities are the key factors anticipating the drive of Intravenous Therapy and Vein Access Market growth.
Another key factor that drives the Intravenous Therapy Industry growth is an increase in demand for IVs as an effective and fast-acting way to administer fluid or medication in an emergency situation and for patients who are unable to take medications orally. Approximately 80% of all patients in hospital settings receive IV therapy.
The Intravenous Therapy and Vein Access Market are segmented on the basis of type, medical application, and region. On the basis of type, the market is classified into implantable ports, IV catheters, hypodermic needles, infusion pumps, and others. Depending on medical application, the market is categorized into volume expanders, medication administration, blood-based products, and nutrition & buffer solutions. As per the end-user, the market is fragmented into hospitals, ambulatory surgical centers, and clinics. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA
.
Depending on the type. the IV catheters segment is classified into peripheral IV catheter, center IV catheter, peripherally inserted central catheter, and others. The IV catheters are the fastest growing product segment, owing to the rise in chronic disease and the increase in geriatric population across the globe.
As per the end-user, the hospital segment held the highest market share, owing to an increase in the use of IV therapy in hospitals, which includes IV antibiotic treatment, medication for unconscious patients, drugs that cannot be orally administered, interventional radiology, anti-cancer drugs, hemodialysis, repeated blood sample drawings, and blood transfusion. Advancements in technology and investment in hospitals boost the growth of IV therapy and vein access device market.
Region-wise, it is analyzed, North America was the highest Intravenous Therapy and Vein Access Market share in 2020, owing to the advanced healthcare infrastructure and use of the latest equipment with updated technologies. Asia-Pacific is expected to be the fastest-growing region, owing to the demand advanced technologies and an increase in the prevalence of kidney disorders & diabetes.
Key findings of the Study
- Depending on the type, the IV catheters were the highest contributor to the market in 2020.
- By application type, medical administration dominated the market in 2020 and is expected to continue this trend during the forecast period.
- Region-wise, North America garnered the largest revenue share in 2020; however, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Companies Mentioned
- Medtronic Inc
- Teleflex
- B. Braun Melunsung
- terumo corporation
- AngioDynamics, Inc.
- Fresenius SE and Co. KGaA.
- Baxter international plc
- Pfizer Inc
- Cardinal Health Inc.
- smiths medical
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 214 |
| Published | March 2022 |
| Forecast Period | 2020 - 2030 |
| Estimated Market Value ( USD | $ 22808.93 million |
| Forecasted Market Value ( USD | $ 37537.18 million |
| Compound Annual Growth Rate | 5.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
